Cardiovascular and Metabolic Disorders

Featured Article

Cross-Sex Hormone Therapy: What Are the Long-Term Risk Factors?

Cross-Sex Hormone Therapy: What Are the Long-Term Risk Factors?

Primary prevention of cardiovascular disease through risk factor modification, including tobacco cessation, maintenance of a body mass index, and management of abnormal lipid levels, diabetes, and hypertension, is of great importance for the health of transgender individuals.

Latest

Strategies for Multivessel Revascularization in T1D: CABG vs PCI

Strategies for Multivessel Revascularization in T1D: CABG vs PCI

PCI has been linked to increased risk of CHD, mortality, MI, and repeat revascularization in type 1 diabetes.

Cardiovascular, Renal Outcomes in Type 1 Diabetes

Cardiovascular, Renal Outcomes in Type 1 Diabetes

More awareness for afib risk factors including age, severity of complications, and glycemic status are needed.

Lowering Heart Failure Hospitalizations in T2D: SGLT2 vs DPP4 Inhibitors

Lowering Heart Failure Hospitalizations in T2D: SGLT2 vs DPP4 Inhibitors

A retrospective analysis examined outcomes in patients with type 2 diabetes treated with SGLT2 vs DPP4 inhibitors.

Population at Risk: CVD Events Increased in Metabolically Healthy Obese

Population at Risk: CVD Events Increased in Metabolically Healthy Obese

Researchers created body size phenotypes, defined by BMI category, to assess CVD incidence in a metabolically healthy obese population.

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Atrial Fibrillation With Diabetes: Risk for Cardiovascular Events in Women vs Men

Women with atrial fibrillation and diabetes had a higher risk for mortality and cardiovascular complications compared with men.

Examined: Correlation Between Weight Increase and Heart Failure Risk

Examined: Correlation Between Weight Increase and Heart Failure Risk

Losing weight may result in a decrease of heart muscle thickness.

Cardiovascular Event Risks With Zoledronic Acid vs Oral Bisphosphonates

Cardiovascular Event Risks With Zoledronic Acid vs Oral Bisphosphonates

Patients treated with zoledronic acid vs oral bisphosphonates had higher risk for heart failure and arrhythmias.

Comparing Early, Delayed Invasive Strategy in Non-ST-Elevation Acute Coronary Syndromes

Comparing Early, Delayed Invasive Strategy in Non-ST-Elevation Acute Coronary Syndromes

An early invasive strategy in patients with non-ST-elevation acute coronary syndromes does not necessarily reduce mortality compared with a delayed strategy.

FDA Approves Pitavastatin for Hyperlipidemia, Mixed Dyslipidemia

FDA Approves Pitavastatin for Hyperlipidemia, Mixed Dyslipidemia

Multiple clinical studies have examined the efficacy of pitavastatin.

A Polygenic Risk for Severe Hypertriglyceridemia: Case Study

A Polygenic Risk for Severe Hypertriglyceridemia: Case Study

Researchers urge physicians to consider polygenic causes for patients with severe hypertriglyceridemia.

Sign Up for Free e-Newsletters